Product Code: GVR-2-68038-782-7
3D Medical Imaging Devices Market Growth & Trends:
The global 3D medical imaging devices market is estimated to reach USD 20.31 billion by 2030, registering a CAGR of 8.11% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing prevalence of cardiovascular diseases, Alzheimer's, cancer, and other chronic diseases. Moreover, the rise in healthcare expenditure across developed economies and rapid technological advancements are some of the other factors responsible for the market growth.
Furthermore, continuous advancements in imaging technology play an important role in driving market growth. Innovations in modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound have led to higher-resolution 3D imaging, allowing for more precise and detailed visualization of anatomical structures and pathological conditions. Healthcare providers are increasingly seeking state-of-the-art imaging equipment, which fuels the demand for 3D medical imaging devices.
Competition among medical device manufacturers and the introduction of new and innovative 3D imaging devices are driving market growth as companies strive to offer cutting-edge solutions. For instance, in August 2023, GigXR, Inc. launched an application, XR Library, which is driven by INTRAVISION XR, as part of its immersive learning platform. This innovative application provides a comprehensive collection of 3D medical visuals derived from CT and MRI scans. Similarly, in September 2022, GE Healthcare received FDA authorization for its AIR Recon, an advanced 3D and motion-insensitive imaging applications. This development promises to enhance the overall quality of MRI images while providing a more enhanced experience for patients. These factors are further contributing to market growth.
3D Medical Imaging Devices Market Report Highlights:
- In terms of applications, the oncology segment dominated the market in 2024 with a revenue share of more than 33%. The growth of the segment is attributed to the increasing prevalence of cancer globally.
- In terms of end-use, the hospitals segment dominated the market in 2024 with the largest revenue share of 48%. Hospitals offer a wide range of medical services, from routine check-ups to complex surgeries and specialized treatments. These factors have boosted the demand for medical imaging devices.
- Based on region, North America held the largest revenue share of about 35.8% in 2024. The growth is attributed to the growing adoption of minimally invasive surgeries and increasing demand for novel technologies.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Device type
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Device type outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. 3D Medical Imaging Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Technological advancements
- 3.2.1.2. Increasing geriatric population
- 3.2.1.3. Government initiatives
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost associated with 3D medical imaging devices
- 3.2.2.2. Complex regulatory environment
- 3.3. 3D Medical Imaging Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. 3D Medical Imaging Devices Market: Device Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global 3D Medical Imaging Devices Type Market Movement Analysis
- 4.3. Global 3D Medical Imaging Devices Market Size & Trend Analysis, by Device Type, 2018 to 2030 (USD Million)
- 4.4. Hardware
- 4.4.1. Hardware market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.1. X-ray devices
- 4.4.1.1.1. X-ray devices market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.2. CT devices
- 4.4.1.2.1. CT devices market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.3. Ultrasound systems
- 4.4.1.3.1. Ultrasound systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.4. MRI equipment
- 4.4.1.4.1. MRI equipment market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Software
- 4.5.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. 3D Medical Imaging Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global 3D Medical Imaging Devices Application Market Movement Analysis
- 5.3. Global 3D Medical Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Oncology
- 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Cardiology
- 5.5.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Orthopedic
- 5.6.1. Orthopedic market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Gynecology
- 5.7.1. Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. 3D Medical Imaging Devices Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global 3D Medical Imaging Devices End Use Market Movement Analysis
- 6.3. Global 3D Medical Imaging Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Diagnostic Imaging Centers
- 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. 3D Medical Imaging Devices Market: Regional Estimates & Trend Analysis By Product, Application, End Use
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework
- 7.5.1.4. Reimbursement structure
- 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement structure
- 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement structure
- 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Competitive scenario
- 7.6.1.3. Regulatory framework
- 7.6.1.4. Reimbursement structure
- 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement structure
- 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement structure
- 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework
- 7.6.4.4. Reimbursement structure
- 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework
- 7.6.5.4. Reimbursement structure
- 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework
- 7.6.6.4. Reimbursement structure
- 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework
- 7.6.7.4. Reimbursement structure
- 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Competitive scenario
- 7.6.8.3. Regulatory framework
- 7.6.8.4. Reimbursement structure
- 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement structure
- 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement structure
- 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement structure
- 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement structure
- 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement structure
- 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive scenario
- 7.7.6.3. Regulatory framework
- 7.7.6.4. Reimbursement structure
- 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Competitive scenario
- 7.8.1.3. Regulatory framework
- 7.8.1.4. Reimbursement structure
- 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. Reimbursement structure
- 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Competitive scenario
- 7.9.1.3. Regulatory framework
- 7.9.1.4. Reimbursement structure
- 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive scenario
- 7.9.2.3. Regulatory framework
- 7.9.2.4. Reimbursement structure
- 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive scenario
- 7.9.3.3. Regulatory framework
- 7.9.3.4. Reimbursement structure
- 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Competitive scenario
- 7.9.4.3. Regulatory framework
- 7.9.4.4. Reimbursement structure
- 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market share analysis, 2024
- 8.4. Company Position Analysis
- 8.5. Company Categorization (Emerging Players, Innovators and Leaders
- 8.6. Company Profiles
- 8.6.1. Siemens Healthineers
- 8.6.1.1. Company overview
- 8.6.1.2. Financial performance
- 8.6.1.3. Product benchmarking
- 8.6.1.4. Strategic initiatives
- 8.6.2. Esaote SpA
- 8.6.2.1. Company overview
- 8.6.2.2. Financial performance
- 8.6.2.3. Product benchmarking
- 8.6.2.4. Strategic initiatives
- 8.6.3. Koninklijke Philips N.V.
- 8.6.3.1. Company overview
- 8.6.3.2. Financial performance
- 8.6.3.3. Product benchmarking
- 8.6.3.4. Strategic initiatives
- 8.6.4. GE Healthcare Ltd.
- 8.6.4.1. Company overview
- 8.6.4.2. Financial performance
- 8.6.4.3. Product benchmarking
- 8.6.4.4. Strategic initiatives
- 8.6.5. Canon Medical Systems
- 8.6.5.1. Company overview
- 8.6.5.2. Financial performance
- 8.6.5.3. Product benchmarking
- 8.6.5.4. Strategic initiatives
- 8.6.6. Hitachi Medical Systems
- 8.6.6.1. Company overview
- 8.6.6.2. Financial performance
- 8.6.6.3. Product benchmarking
- 8.6.6.4. Strategic initiatives
- 8.6.7. Shimadzu Corporation
- 8.6.7.1. Company overview
- 8.6.7.2. Financial performance
- 8.6.7.3. Product benchmarking
- 8.6.7.4. Strategic initiatives
- 8.6.8. DigiRad Corporation
- 8.6.8.1. Company overview
- 8.6.8.2. Financial performance
- 8.6.8.3. Product benchmarking
- 8.6.8.4. Strategic initiatives
- 8.6.9. Del Medical Systems Inc.
- 8.6.9.1. Company overview
- 8.6.9.2. Financial performance
- 8.6.9.3. Product benchmarking
- 8.6.9.4. Strategic initiatives